MALLORY BROWN: Open Payments
NPI 1275390817 · STEPHENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 31 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $204 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $64 |
| Exact Sciences Corporation | 4 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| ABBVIE INC. | 2 | $49 |
| Amgen Inc. | 2 | $35 |
| Soleno Therapeutics, Inc. | 1 | $35 |
| Biogen, Inc. | 1 | $27 |
Products named: Ozempic, JARDIANCE, REXULTI, TZIELD, Jornay PM, VRAYLAR, Cologuard Collection Kit, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
